@article{7798b53e798947a19297468dcaffa951,
title = "Reply to Eisen and Denholm, Dauchy et al, Fierer, and Nguyen and Jones",
author = "Osmon, {Douglas R.} and Berbari, {Elie F.} and Berendt, {Anthony R.} and Daniel Lew and Werner Zimmerli and Steckelberg, {James M.} and Nalini Rao and Arlen Hanssen and Wilson, {Walter R.}",
note = "Funding Information: D. R. O. has received research grants from Cubist Pharmaceuticals and Ortho-McNeil. E. F. B. has received funding from Cubist Pharmaceuticals, Ortho McNeil, Orthopedic Research, and Education Foundation and Mayo. A. H. has received royalties from Stryker Corp for hip/knee design. W. Z. has served as a board member of Pfizer and on the speakers{\textquoteright} bureaus of Pfizer and Synthes, Inc. D. L. is a member of the Board of Basilea. A. R. B. was awarded a Pfizer Visiting Professorship to the Department of Allergy and Infectious Diseases at the University of Washington, Seattle. All other authors report no potential conflicts.",
year = "2013",
month = jul,
doi = "10.1093/cid/cit189",
language = "English (US)",
volume = "57",
pages = "162--164",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "1",
}